The regulatory file for bovine colostrum
Bovine colostrum reaches food-supplement markets under general food law, and what decides a launch is narrower than the permission question: the milk allergen statement, the contaminant results, the label wording and the documents that name the bovine source. The buyer's regulatory team confirms the route for the destination. This page lists the framework and the papers that belong in the file, so the specification and the commercial pack can be reviewed together.
The specification describes the powder; the regulatory file names the milk allergen, the contaminant results and the route that the buyer's team confirms for the destination.
What the file has to answer
A supplier file has to close four gaps before a launch. It has to define the material and pin the revision of the specification being bought. It has to connect a released lot to its certificate. It has to show the limits and label rules that apply to the finished product in the destination. And it has to say what happens when the source, the process or the pack changes.
The certificate answers the lot question, the technical data sheet answers the specification question, and the safety data sheet answers the handling question. None of the three settles the route question, which is why the file needs a written statement of the basis, matched to the market.
Colostrum is a product of animal origin and an ingredient in its own right. The raw-material records, the veterinary status of the herd and the hygiene controls behind the powder are part of the supply chain, and a buyer who asks for the process description and the origin declaration is asking the right questions.
The European Union
A colostrum powder for food supplements sits under Directive 2002/46/EC and the general food law around it, with Regulation (EU) No 1169/2011 for labelling, Regulation (EC) No 1924/2006 for claims and Regulation (EU) 2023/915 for contaminants. The permission question is separate, and it is settled per material: colostrum, a defatted colostrum, a basic-protein fraction and an IgG isolate are different articles, and each has to be checked against the current novel-food catalogue rather than assumed from the history of the whole secretion.
The allergen rule is the one that catches formulators. Annex II of Regulation 1169/2011 lists milk and products thereof, including lactose, so the finished supplement must name milk in the ingredient list and give it the emphasis the regulation requires. A “may contain milk” note is not a substitute for declaring an ingredient that is present.
This page describes the framework as of this review. The consolidated text of each instrument, and the position for the exact material, decide.
The United States
A dietary supplement containing colostrum is made under 21 CFR 111 and labelled with a Supplement Facts panel. The ingredient basis has to be stated in writing: whether the material is a pre-1994 dietary ingredient, is covered by a GRAS conclusion for the intended use, or has a new dietary ingredient notification. Those are three different routes, and the customer's own filing depends on which one applies.
Milk is a major food allergen under FALCPA, so the label carries the milk declaration through the “Contains” statement or the ingredient-list emphasis. The supplier's allergen statement should use wording that the customer's label can adopt without translation. Proposition 65 is a separate warning regime that can apply to lead even where the federal rules set no limit.
Contaminants and microbiology
A drum result is the starting figure, not the answer: the finished-product dose turns it into what the consumer takes. The table below pairs the catalog limits with the reference a supplement file usually starts from; the current destination text and the daily dose decide the final number.
| Parameter | Catalog limit | Reference to confirm |
|---|---|---|
| Lead | ≤3 mg/kg | EU supplement maximum 3.0 mg/kg; Prop 65 |
| Arsenic | ≤2 mg/kg | No EU supplement level; member-state rules |
| Cadmium | ≤1 mg/kg | EU supplement maximum 1.0 mg/kg |
| Mercury | ≤0.1 mg/kg | EU supplement maximum 0.10 mg/kg |
| Total aerobic count | ≤1,000 cfu/g | Contractual; no EU supplement count |
| Yeast and mould | ≤100 cfu/g | Contractual release criterion |
| E. coli and Salmonella | Absent | Contractual release criterion |
A lot released against these limits sits on the EU maxima rather than below them, which leaves the finished-product calculation no headroom to absorb; a customer who wants margin should write a tighter internal limit. Microbiology is not harmonised for supplements in the same way, which makes the counts contractual and worth writing into the specification.
Where the claims stop
An EU health claim is usable only when it appears in the authorised register under Regulation (EC) No 1924/2006 and the wording and conditions of use match the entry; a disclaimer does not turn an unauthorised wording into a permitted one. US labelling allows structure or function statements with the DSHEA disclaimer and does not allow disease claims. The UK applies retained equivalents. Each of these reviews the wording on the finished label, not the ingredient's specification, and a certificate cannot approve a claim.
This site makes no physiological claim for colostrum. The pages describe identity, composition, process behaviour and documents. “IgG ≥20.0%” is a specification term, not a claim, and it should be defined so that the pack and the certificate mean the same thing.
The documents a file needs
- The specification, with protein and its factor, IgG and its method, fat, lactose, moisture, particle size, metals and microbiology.
- The batch COA for the lot, with the same parameter set and the lot number.
- The technical data sheet and the storage and retest statement for the pack.
- The milk allergen statement, in the wording the destination label will use, including the lactose position.
- The origin and species declaration: bovine, with the milk source and the country of collection.
- A TSE/BSE statement covering the bovine source, even though milk is not a specified risk material.
- The contaminant and microbiology reports, and a stability summary for the grade and pack sold.
- A third-party report when the destination market or the customer's own procedure asks for one.
Keep the versions together: a specification, a certificate and a label on different revisions will not survive a border check.
The release checklist
- Does the COA name the lot, the grade and the IgG method?
- Is the protein figure accompanied by its nitrogen factor?
- Does the allergen statement name milk in the wording the label will use?
- Do the heavy metals sit inside the catalog limits, and does the customer want a tighter internal limit?
- Is the ingredient basis for the destination stated in writing, for this exact material?
- Does one lot number appear on the pack, the COA and the retained sample?
- Has the claim wording been reviewed separately from the specification?
The product page carries the catalog specification, the identity page shows the tests behind the source statement, the MOQ page shows how the documents attach to an order, the methods notes describe the assays, and the quality page holds the release file.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation